Genesis HealthCare (GEN) Reports In-Line Q4 Loss

Genesis HealthCare (NYSE: GEN) reported Q4 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.42 billion.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• Investing.com’s stocks of the week